Literature DB >> 8394366

Expression of insulin-like growth factor receptors I and II in normal human lung and in lung cancer.

U Kaiser1, C Schardt, D Brandscheidt, E Wollmer, K Havemann.   

Abstract

Insulin-like growth factors are potent mitogenic factors in human lung cancer in vitro, acting via specific receptors. Using monoclonal antibodies we demonstrate the expression of insulin-like growth factor receptor I in bronchial epithelial cells of normal lung and in primary lung cancer (22/24 cases), being most prominent in squamous cell carcinoma. Electron microscopy on lung cancer cell lines reveals a distinct reaction pattern on the plasma membrane. Immunoreaction with a specific antibody directed against the insulin-like growth factor receptor II suggests a weak expression in primary lung cancer. Our findings underline the significance of the autocrine pathway of insulin-like growth factors in lung cancer.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8394366     DOI: 10.1007/bf01215985

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  18 in total

1.  Somatomedin-C receptors and growth effects in human breast cells maintained in long-term tissue culture.

Authors:  R W Furlanetto; J N DiCarlo
Journal:  Cancer Res       Date:  1984-05       Impact factor: 12.701

2.  Monoclonal antibodies to receptors for insulin and somatomedin-C.

Authors:  F C Kull; S Jacobs; Y F Su; M E Svoboda; J J Van Wyk; P Cuatrecasas
Journal:  J Biol Chem       Date:  1983-05-25       Impact factor: 5.157

3.  Prognostic significance of insulin-like growth factor 1 receptors in human breast cancer.

Authors:  J Bonneterre; J P Peyrat; R Beuscart; A Demaille
Journal:  Cancer Res       Date:  1990-11-01       Impact factor: 12.701

4.  Partial characterization of insulin-like growth factor I in primary human lung cancers using immunohistochemical and receptor autoradiographic techniques.

Authors:  K Shigematsu; Y Kataoka; T Kamio; M Kurihara; M Niwa; H Tsuchiyama
Journal:  Cancer Res       Date:  1990-04-15       Impact factor: 12.701

5.  Autocrine function for insulin-like growth factor I in human small cell lung cancer cell lines and fresh tumor cells.

Authors:  V M Macaulay; M J Everard; J D Teale; P A Trott; J J Van Wyk; I E Smith; J L Millar
Journal:  Cancer Res       Date:  1990-04-15       Impact factor: 12.701

6.  Insulin-like growth factor-1 receptors and insulin-like growth factor-1-like activity in human primary breast cancer.

Authors:  J A Foekens; H Portengen; M Janssen; J G Klijn
Journal:  Cancer       Date:  1989-06-01       Impact factor: 6.860

7.  Evidence for an increased somatomedin-C/insulin-like growth factor I content in primary human lung tumors.

Authors:  F Minuto; P Del Monte; A Barreca; P Fortini; G Cariola; G Catrambone; G Giordano
Journal:  Cancer Res       Date:  1986-02       Impact factor: 12.701

8.  Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro.

Authors:  Y Nakanishi; J L Mulshine; P G Kasprzyk; R B Natale; R Maneckjee; I Avis; A M Treston; A F Gazdar; J D Minna; F Cuttitta
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

9.  Is movement of mannose 6-phosphate-specific receptor triggered by binding of lysosomal enzymes?

Authors:  T Braulke; C Gartung; A Hasilik; K von Figura
Journal:  J Cell Biol       Date:  1987-06       Impact factor: 10.539

10.  The use of lead citrate at high pH as an electron-opaque stain in electron microscopy.

Authors:  E S REYNOLDS
Journal:  J Cell Biol       Date:  1963-04       Impact factor: 10.539

View more
  9 in total

1.  Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt.

Authors:  G Kulik; A Klippel; M J Weber
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

2.  Discovery of novel insulin-like growth factor-1 receptor inhibitors with unique time-dependent binding kinetics.

Authors:  Meizhong Jin; Brenda A Petronella; Andy Cooke; Mridula Kadalbajoo; Kam W Siu; Andrew Kleinberg; Earl W May; Prafulla C Gokhale; Ryan Schulz; Jennifer Kahler; Mark A Bittner; Kenneth Foreman; Jonathan A Pachter; Robert Wild; David Epstein; Mark J Mulvihill
Journal:  ACS Med Chem Lett       Date:  2013-05-23       Impact factor: 4.345

3.  Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis.

Authors:  R O'Connor; A Kauffmann-Zeh; Y Liu; S Lehar; G I Evan; R Baserga; W A Blättler
Journal:  Mol Cell Biol       Date:  1997-01       Impact factor: 4.272

4.  Modulation of annexin I and cyclooxygenase-2 in smokeless tobacco-induced inflammation and oral cancer.

Authors:  Jamboor K Vishwanatha; Ryan Swinney; Abhijit G Banerjee
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

5.  Randomized, phase III trial of first-line figitumumab in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin alone in patients with advanced non-small-cell lung cancer.

Authors:  Corey J Langer; Silvia Novello; Keunchil Park; Maciej Krzakowski; Daniel D Karp; Tony Mok; Rebecca J Benner; Judith R Scranton; Anthony J Olszanski; Jacek Jassem
Journal:  J Clin Oncol       Date:  2014-06-02       Impact factor: 44.544

6.  Mass spectrometric characterization of a series of adenosylated peptides acting as bisubstrate analogs of protein kinases.

Authors:  B W Gibson; D Medzihradszky; W M Hines; S Auriola; G L Kenyon
Journal:  J Am Soc Mass Spectrom       Date:  1994-05       Impact factor: 3.109

7.  Targeting non-small cell lung cancer cells by dual inhibition of the insulin receptor and the insulin-like growth factor-1 receptor.

Authors:  Emma E Vincent; Douglas J E Elder; Jon Curwen; Elaine Kilgour; Ingeborg Hers; Jeremy M Tavaré
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

Review 8.  Modulation of insulin-like growth factor-1 receptor and its signaling network for the treatment of cancer: current status and future perspectives.

Authors:  Meizhong Jin; Elizabeth Buck; Mark J Mulvihill
Journal:  Oncol Rev       Date:  2013-04-22

Review 9.  Targeting the IGF-1R: The Tale of the Tortoise and the Hare.

Authors:  Caitrin Crudden; Ada Girnita; Leonard Girnita
Journal:  Front Endocrinol (Lausanne)       Date:  2015-04-27       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.